Abstract
Background: Maternal obesity is related to immunologic and inflammatory systemic modifications that may worsen the pregnancy inflammatory status. Hormonal changes during pregnancy can adversely affect oral biofilms and oral health initiating or worsening periodontal diseases, with enhanced local and systemic oxidative stress and inflammation. Objective: The aim of this study was to examine the relationship between local salivary and systemic parameters of oxidative stress and inflammation in relation to obesity and periodontal diseases. Study Design: Sixty-two women with singleton pregnancies were enrolled. Twenty-seven women were normal weight (NW; 18.5< body mass index [BMI] <25 kg/m2) and 35 obese (BMI ≥30 kg/m2). Seventeen of the obese had gestational diabetes mellitus (GDM). During third trimester, periodontal status was evaluated, saliva (s) was collected to assess total antioxidant capacity (s-TAC) and C-reactive protein (s-CRP) levels, and venous plasma (p) was used to measure CRP levels (p-CRP). Maternal, fetal, and placental data were registered at delivery. Results: Levels of s-TAC, s-CRP, and p-CRP were significantly higher in obese, particularly in the presence of GDM, compared to NW and related to each other (P = .000; r > 0.59), to maternal BMI (P =. 000; r > 0.52), and fasting glycemia (P <.002; r > 0.47). Periodontal disease was more frequent in obese groups (80%) versus NW (52%; P = .04), particularly when GDM was diagnosed (P = .009). A significant interaction effect between maternal BMI and oral condition was found for s-TAC levels. Obese with periodontitis showed significant increase in local and systemic parameters versus NW. Conclusion: Obesity and periodontal disease could synergistically amplify the inflammatory and oxidative status, resulting in increased local and systemic biomarkers particularly when GDM is diagnosed.
Similar content being viewed by others
References
World Health Organization. “Obesity and Overweight”, Fact Sheet, no. 311. Geneva, Switzerland: World Health Organization; 2011.
Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med. 2010; 15(2):70–76.
Berglund SK, Garc´ıa-Valde´s L, Torres-Espinola FJ, et al. Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE). BMC Public Health. 2016;16:207.
Catalano P, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;356:11.
Poston L, Harthoorn LF, Van Der Beek, Eline M; Contributors ILSI Europe Workshop. Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement. Pediatr Res. 2011;69(2):175–180.
Zilberlicht A, Feferkorn I, Younes G, et al. The mutual effect of pregestational body mass index, maternal hyperglycemia and gestational weight gain on adverse pregnancy outcomes. Gynecol Endocrinol. 2016;32(5):416–420.
Spradley FT, Palei AC, Granger JP. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol. 2015; 309(11):R1326–R1343.
Wallace JM, Horgan GW, Bhattacharya S. Placental weight and efficiency in relation to maternal body mass index and the risk of pregnancy complications in women delivering singleton babies. Placenta. 2012;33(8):611–618.
Hayes EK, Lechowicz A, Petrik JJ, et al. Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental Vasculature. PLoS One. 2012;7(3):e33370.
Reece EA. Obesity, diabetes, and links to congenital defects: a review of the evidence and recommendations for intervention. J Matern Fetal Neonatal Med. 2008;21(3):173–180.
Roberts VH, Frias AE, Grove KL. Impact of maternal obesity on fetal programming of cardiovascular disease. Physiology (Bethesda). 2015;30(3):224–231.
Vasudevan C, Renfrew M, McGuire W. Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed. 2011;96(5):F378–F382.
Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death. A systematic review and meta-analysis. JAMA. 2014; 311(15):1536–1546.
Lee HJ, Jun JK, Lee SM, Ha JE, Paik DI, Bae KH. Association between obesity and periodontitis in pregnant females. J Periodontol. 2014;85(7):e224–e231.
Offenbacher S, Boggess KA, Murtha AP, et al. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol. 2006;107(1):29–36.
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366(9499):1809–1820.
Ide M, Linden G. Periodontitis, cardiovascular disease and pregnancy outcome—focal infection revisited? Br Dent J. 2014; 217(8):467–474.
Chaparro A, Sanz A, Quintero A, et al. Increased inflammatory biomarkers in early pregnancy is associated with the development of pre-eclampsia in patients with periodontitis: a case control study. J Periodontal Res. 2013;48(3):302–307.
Ide M, Papapanou PN. Epidemiology of association between maternal periodontal disease and adverse pregnancy out-comes—systematic review. J Clin Periodontol. 2013;40(suppl 14):S181–S194.
Moutsopoulos NM, Madianos PN. Lowgrade inflammation in chronic infectious diseases: Paradigm of periodontal infections. Ann N Y Acad Sci. 2006;1088:251–264.
Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011; 12(5):3117–3132.
Pantham P, Aye IL, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta. 2015; 36(7):709–715.
Daigo K, Inforzato A, Barajon I, et al. Pentraxins in the activation and regulation of innate immunity. Immunol Rev. 2016;274(1):202–217.
Herna´ndez-Trejo M, Montoya-Estrada A, Torres-Ramos Y, et al. Oxidative stress biomarkers and their relationship with cytokine concentrations in overweight/obese pregnant women and their neonates. BMC Immunol. 2017;18(1):3.
Sen S, Iyer C, Meydani SN. Obesity during pregnancy alters maternal oxidant balance and micronutrient status. J Perinatol. 2014;34(2):105–111.
Novielli C, Mandò C, Tabano S, et al. Mitochondrial DNA content and methylation in fetal blood of pregnancies with placental insufficiency. Placenta. 2017;55:63–70.
Mandò C, Razini P, Novielli C, et al. Impaired angiogenic potential of human placental mesenchymal stromal cells in intrauterine growth restriction. Stem Cells Transl Med. 2016;5(4):451–463.
Mandò C, Novielli C, Anelli G, Clivio V, Cardellicchio M, Cetin I. Alterations of mitochondrial content in obese placentas. Reprod Sci. 2015;22:374A–374A.
Anelli GM, Cardellicchio M, Novielli C, et al. Mitochondrial content and hepcidin are increased in obese pregnant mothers. J Matern Fetal Neonatal Med. 2017:1–8. In Press.
Desai GS, Mathews ST. Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J Diabet. 2014; 5(6):730.
Mandò C, Calabrese S, Mazzocco MI, et al. Sex specific adaptations in placental biometry of overweight and obese women. Placenta. 2016;38:1–7.
Institute of Medicine (US) and National Research Council (US). Committee to reexamine IOM pregnancy weight guidelines. In: Rasmussen KM, Yaktine AL, eds. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press; 2009.
Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(suppl 3):S173–S211.
Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007;78(suppl 7): 1387–1399.
Knoflach M, Kiechl S, Mantovani A, et al. Pentraxin-β as a marker of advanced atherosclerosis results from the bruneck, army and arfy studies. PLoS One. 2012;7(2):e31474.
Jung UJ, Choi M-S. obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–6223.
Ha AW, Jeong SY, Kang NE, Kim WK. Plasma adipocytokines and antioxidants-status in Korean overweight and obese females with dyslipidemia. Nutr Res Pract. 2014;8(4):417–424.
Li H, Yin Q, Li N, Ouyang Z, Zhong M. Plasma markers of oxidative stress in patients with gestational diabetes mellitus in the second and third trimester. Obstet Gynecol Int. 2016;2016: 3865454.
Marseglia L, Manti S, D’Angelo G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2015;16(1):378–400.
Dursun E, Akaln FA, Genc T, Cinar N, Erel O, Yildiz BO. Oxidative stress and periodontal disease in obesity. Medicine (Baltimore). 2016;95(12):e3136.
Atabay VE, Lutfiog˘lu M, Avci B, et al. Obesity and oxidative stress in patients with different periodontal status: a case-control study. J Periodontal Res. 2017;52(1):51–60.
Almerich-Silla JM, Montiel-Company JM, Pastor S, Serrano F, Puig-Silla M, Dası´ F. Oxidative stress parameters in saliva and its association with periodontal disease and types of bacteria. Dis Markers. 2015;2015:653537.
Su H, Gornitsky M, Velly AM, et al. Salivary DNA, lipid, and protein oxidation in nonsmokers with periodontal disease. Free Radic Biol Med. 2009;46(7):914–921.
Surdacka A, Ciężka E, Pioruńska-Stolzmann M, et al. Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes. Arch Oral Biol. 2011;56(5):428–436.
Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004;279(47):48487–48490.
Mei Z, Li H, Serdula MK, et al. -Creactive protein increases with gestational age during pregnancy among Chinese women: C-reactive protein in normal pregnancy. Am J Hum Biol. 2016; 28(4):574–579.
Cetin I, Cozzi V, Pasqualini F, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2006;194(5):1347–1353.
Cozzi V, Garlanda C, Nebuloni M, et al. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta 2012;33(12):1039–1044.
Rovere-Querini P, Antonacci S, Dell’Antonio G, et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006;108(1):148–155.
Yamasaki K, Kurimura M, Kasai T, et al. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med. 2009;47(4):471–477.
Palle AR, Reddy CM, Shankar BS, et al. Association between obesity and chronic periodontitis: a cross-sectional study. J Contemp Dent Pract. 2013;14(2):168–173.
Saito T, Shimazaki Y, Sakamoto M. Obesity and periodontitis. N Engl J Med. 1998;339(7):482–483.
Baltacioglu E, Kehribar M, Yuva P, et al. Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis. J Periodontol. 2014; 85(2):317–326.
Wei D, Zhang X, Wang Y, et al. Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J. 2010;55(1):70–78.
Tothova L, Kamodyova N, Cervenka T, Celec P. Salivary markers of oxidative stress in oral diseases. Front Cell Infect Microbiol. 2015;5:73.
Esteves Lima RP, Cyrino RM, de Carvalho Dutra B, et al. Association between periodontitis and gestational diabetes mellitus: systematic review and meta-analysis. J Periodontol. 2016;87(1):48–57.
Myatt L, Maloyan A. Obesity and placental function. Semin Reprod Med. 2016;34(1):42–49.
Howell KR, Powell TL. Effects of maternal obesity on placental function and fetal development. Reproduction. 2017;153(3): R97–R108.
Gabbay-Benziv R, Observer V. Gestational diabetes as one of the “great obstetrical syndromes”—the maternal, placental, and fetal dialog. Best Pract Res Clin Obstetr Gynaecol. 2015; 29(2):150–155.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zambon, M., Mandò, C., Lissoni, A. et al. Inflammatory and Oxidative Responses in Pregnancies With Obesity and Periodontal Disease. Reprod. Sci. 25, 1474–1484 (2018). https://doi.org/10.1177/1933719117749758
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719117749758